Maximilian Foerst to Depart as CEO of Carl Zeiss Meditec AG

JENA, Germany—Zeiss Group Global has announced that the supervisory boards of Carl Zeiss AG and Carl Zeiss Meditec AG have reached a mutual agreement with Maximilian Foerst, CEO of Carl Zeiss Meditec AG and member of the executive board of Carl Zeiss AG responsible for the medical technology segment, to “end their collaboration prematurely as of December 31, 2025.” In making the announcement, the company said that “The background to this decision is non-compliant conduct by Maximilian Foerst in his previous role, unrelated to the business operations of the Zeiss Group.”